These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 9887243)
21. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726 [TBL] [Abstract][Full Text] [Related]
22. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109 [TBL] [Abstract][Full Text] [Related]
23. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer. Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977 [TBL] [Abstract][Full Text] [Related]
24. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases. Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159 [TBL] [Abstract][Full Text] [Related]
25. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer. Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma. Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107 [TBL] [Abstract][Full Text] [Related]
27. Adjunctive use of the uterine artery resistance index in the preoperative prediction of myometrial invasion in endometrial carcinoma. Develioğlu OH; Bilgin T; Yalçin OT; Ozalp S; Ozan H Gynecol Oncol; 1999 Jan; 72(1):26-31. PubMed ID: 9889025 [TBL] [Abstract][Full Text] [Related]
29. A novel model to estimate lymph node metastasis in endometrial cancer patients. Anton C; E Silva AS; Baracat EC; Dogan NU; Köhler C; Carvalho JP; di Favero GM Clinics (Sao Paulo); 2017 Jan; 72(1):30-35. PubMed ID: 28226030 [TBL] [Abstract][Full Text] [Related]
30. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection]. Ivanov I Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272 [TBL] [Abstract][Full Text] [Related]
31. Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound. Hsieh CY; Wu CC; Chen TM; Chen CA; Chen CL; Wang JF; Chang CF; Hsieh FJ Cancer; 1995 May; 75(10):2518-22. PubMed ID: 7736396 [TBL] [Abstract][Full Text] [Related]
32. Preoperative selection of patients with low-stage endometrial cancer at high risk of pelvic lymph node metastases. van Doorn HC; van der Zee AG; Peeters PH; Kroeks MV; van Eijkeren MA Int J Gynecol Cancer; 2002; 12(2):144-8. PubMed ID: 11975673 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer. Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890 [TBL] [Abstract][Full Text] [Related]
34. Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer. Bourgioti C; Chatoupis K; Tzavara C; Antoniou A; Rodolakis A; Moulopoulos LA Abdom Radiol (NY); 2016 Dec; 41(12):2484-2495. PubMed ID: 27714421 [TBL] [Abstract][Full Text] [Related]
35. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma. Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132 [TBL] [Abstract][Full Text] [Related]
36. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer. Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481 [TBL] [Abstract][Full Text] [Related]
37. Factors predicting nodal metastasis in endometrial cancer. Gilani S; Anderson I; Fathallah L; Mazzara P Arch Gynecol Obstet; 2014 Dec; 290(6):1187-93. PubMed ID: 24981050 [TBL] [Abstract][Full Text] [Related]
39. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer. Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586 [TBL] [Abstract][Full Text] [Related]
40. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]